These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2231611)

  • 41. [The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines].
    Gritsenko AN; Lyskovtsev VV; Senova ZP; Skoldinov AP; Stark A; Wunderlich G; Poppe H; Barch R
    Farmakol Toksikol; 1990; 53(3):30-2. PubMed ID: 2387375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiarrhythmic evaluation of verapamil, nifedipine, perhexiline and skf 525-A in four canine models of cardiac arrhythmias.
    Bergey JL; McCallum JD; Nocella K
    Eur J Pharmacol; 1981 Mar; 70(3):331-43. PubMed ID: 7227454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiarrhythmic and cardiovascular profiles of the fused indole compound (3aR,12R,12aR,12bS)-12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydrox yisoquino [2,1,8-lma]carbazol-5(1H)-one hydrochloride 1.5 hydrate.
    Yorikane R; Mizuno H; Itoh Y; Koike H; Miyake S; Shiga H; Kumakura S; Fukami M; Shimoji Y; Hashimoto T
    Arzneimittelforschung; 1991 Nov; 41(11):1130-6. PubMed ID: 1810258
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antiarrhythmic action of penbutolol].
    Boissier JR; Coutte R; Bertin MC; Giudicelli JF
    Therapie; 1974; 29(2):261-9. PubMed ID: 4152641
    [No Abstract]   [Full Text] [Related]  

  • 46. Electrophysiological characterization and antiarrhythmic efficacy of the mixed potassium channel-blocking antiarrhythmic agent AZ13395438 in vitro and in vivo.
    Jacobson I; Duker G; Florentzson M; Linhardt G; Lindhardt E; Nordkam AK; Åstrand A; Carlsson L
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):290-300. PubMed ID: 23307834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progress toward the development of a safe and effective agent for treating reentrant cardiac arrhythmias: synthesis and evaluation of ibutilide analogues with enhanced metabolic stability and diminished proarrhythmic potential.
    Hester JB; Gibson JK; Buchanan LV; Cimini MG; Clark MA; Emmert DE; Glavanovich MA; Imbordino RJ; LeMay RJ; McMillan MW; Perricone SC; Squires DM; Walters RR
    J Med Chem; 2001 Mar; 44(7):1099-115. PubMed ID: 11297456
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
    Rao TS; Seth SD; Manchanda SC; Nayar U
    Arch Int Pharmacodyn Ther; 1989; 302():128-44. PubMed ID: 2636814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and antiarrhythmic activity of new 3-[2-(omega-aminoalkoxy)phenoxy]-4-phenyl-3-buten-2-ones and related compounds.
    Salimbeni A; Manghisi E; Fregnan GB; Prada M
    J Med Chem; 1987 May; 30(5):773-80. PubMed ID: 3572966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids].
    Berdiaev SU; Paliani-Katsitadze NSh; Turilova AI; Kaverina NV; Likhosherstov AM; Lebedeva AS; Ogurtsov VA
    Eksp Klin Farmakol; 1999; 62(4):26-9. PubMed ID: 10513331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antiarrhythmic properties of basic amide derivatives of imidazolidine-2,4-dione and pyrrolidine-2,5-dione II.
    Kieć-Kononowicz K; Byrtus H; Zejc A; Filipek B; Chevallet P
    Farmaco; 1995 May; 50(5):355-60. PubMed ID: 7626171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
    Kozlovski VI; Vdovichenko VP; Chlopicki S; Malchik SS; Praliyev KD; Zcilkibayev OT
    Pol J Pharmacol; 2004; 56(6):767-74. PubMed ID: 15662089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiarrhythmic and hemodynamic effects of an aminosteroid (Org 3001) in the digitalized dog.
    Remme WJ; Verdouw PD; Hagemeyer F
    Eur J Pharmacol; 1976 Mar; 36(1):189-97. PubMed ID: 1261591
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiarrhythmic therapy for ventricular arrhythmias.
    Zimmermann M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S59-64. PubMed ID: 1723121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [2-(2'-hydroxy 2'-substituted) ethyl-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazines--a novel group of substances with anti-arrhythmia activity].
    Filippova OV; Kryzhanovskiĭ SA; Peresada VP; Likhosherstov AM; Vititnova MB; Kaverina NV; Reznikov KM
    Eksp Klin Farmakol; 2003; 66(3):21-5. PubMed ID: 12924227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular activity of the chiral xanthone derivatives.
    Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
    Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New antiarrhythmic agents. 4. 1'-(Aminoalkyl)-1,2,3,4-tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-dione derivatives.
    Tenthorey PA; Ronfeld RA; Feldman HS; Sandberg RV; McMaster PD; Smith ER
    J Med Chem; 1981 Jan; 24(1):47-53. PubMed ID: 7205874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison of the effects of disopyramide, dihydroquinidine and procainamide on 2 types of ventricular arrhythmias].
    Cosnier D; Grimal J; Duchene-Marullaz P
    Therapie; 1971; 26(1):97-107. PubMed ID: 5554772
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of antiarrhythmic activity of captopril and enalaprilat in experimental cardiac arrhythmias in rabbits. Part I.
    Dzielska-Olczak M; Polakowski P; Kubik-Bogucka E
    Pol J Pharmacol; 1998; 50(3):225-31. PubMed ID: 9861630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.